What is Dovato?
IntroductionDovato is a medication used for treating human immunodeficiency virus (HIV) type 1 infection in adults. It is a two-drug combination regimen that contains dolutegravir and lamivudine. The drug was developed by ViiV Healthcare and was approved by the United States Food and Drug Administration (FDA) for use in 2019. In this response, we will discuss the uses, dosages, side effects, and more about Dovato.
UsesDovato is used for the treatment of HIV type 1 infection in adults who have not previously taken any HIV medications or for those whose HIV has been suppressed for at least six months and who have never failed any HIV treatment regimen. It is a complete regimen in a single tablet, which means it has simplified HIV therapy.
DosageThe recommended dosage for Dovato is one tablet (50 mg of dolutegravir and 300 mg of lamivudine) taken orally once daily with or without food.
Side EffectsLike other medications, Dovato has potential side effects that can occur during treatment. Common side effects may include headache, diarrhea, nausea, trouble sleeping, tiredness, and rash. Serious side effects may include allergic reactions, liver problems, and lactic acidosis (a buildup of lactic acid). It is important to discuss all potential side effects with a healthcare professional before starting this medication.
CostThe cost of Dovato may vary depending on the location, health insurance provider, and other factors. According to GoodRx, the average retail price for a 30-day supply of Dovato is around $3,600. However, the cost can be reduced by using coupons or assistance programs.
ConclusionDovato is a medication used for the treatment of HIV type 1 infection in adults. It is a two-drug combination regimen that contains dolutegravir and lamivudine. While it has potential side effects, Dovato is a complete regimen in a single tablet that simplifies HIV therapy. The cost of Dovato may vary, but there are options for reducing costs for eligible patients. As with any medication, it is important to discuss all potential benefits and risks with a healthcare professional before starting treatment.
Frequently Asked Questions about dovato
Dovato is a once-daily, single-pill, 2-drug regimen (2DR) for treatment-naïve HIV infection that combines dolutegravir, an integrase inhibitor (INI), with the nucleoside reverse transcriptase inhibitor (NRTI) lamivudine.
DOVATO is a complete prescription regimen to treat HIV-1 in adults who have not received HIV-1 medicines in the past or to replace their current HIV-1 medicines when their doctor determines they meet certain requirements.
Dovato® is a combination of 50mg of dolutegravir and 300mg of lamivudine. Dovato® (dolutegravir/lamivudine) is the first FDA-approved drug two-drug regimen for treatment-naïve, HIV-1 infected adults. Photo: Business Wire. Dovato® was developed by ViiV Healthcare, a joint venture between GSK, Pfizer, and Shionogi.
Dovato has an average rating of 6.1 out of 10 from a total of 40 reviews on Drugs.com. 49% of reviewers reported a positive experience, while 38% reported a negative experience.
Brand-name vs.
Dovato is available only as a brand-name drug. It doesn't come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
Official answer. Dovato (a 2-drug regimen) has been shown to be as effective as 3- or 4-drug HIV treatments in helping you to reach or stay at undetectable levels (less than 50 copies HIV per mL). Dovato is a single tablet that contains two HIV medicines. It is taken once daily (with or without food).
This is a brand name drug and a generic may be available. The average cost for 30 Tablet(s), 50-300mg each, is $3,371.68. You can buy Dovato at the discounted price of $2,808.49 by using the WebMDRx coupon, a savings of 17%. Even if this drug is covered by Medicare or your insurance, we recommend you compare prices.
DOVATO is an HIV medicine that controls HIV by helping people reach and/or stay undetectable with just 2 medicines in 1 pill. * No other complete HIV pill contains fewer medicines than DOVATO.
Development timeline for Dovato
| Date | Article |
|---|
| Apr 8, 2019 | Approval FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection in Adults with No Antiretroviral (ARV) Treatment History |
Dovato can cause serious, life-threatening side effects. These include severe skin rash and allergic reactions, liver problems, a buildup of lactic acid in the blood (lactic acidosis), and drug interactions.
Official answer. Dovato (a 2-drug regimen) has been shown to be as effective as 3- or 4-drug HIV treatments in helping you to reach or stay at undetectable levels (less than 50 copies HIV per mL). Dovato is a single tablet that contains two HIV medicines. It is taken once daily (with or without food).
This is a brand name drug and a generic may be available. The average cost for 30 Tablet(s), 50-300mg each, is $3,371.68. You can buy Dovato at the discounted price of $2,808.49 by using the WebMDRx coupon, a savings of 17%. Even if this drug is covered by Medicare or your insurance, we recommend you compare prices.
As with other drugs, Dovato can cause side effects, such as headache, nausea, and insomnia. Dovato contains two active drugs: dolutegravir and lamivudine. Dolutegravir belongs to a drug class called integrase inhibitors.
